I1DX34 Stock Overview
Develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
IDEXX Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$534.53 |
| 52 Week High | US$575.20 |
| 52 Week Low | US$476.97 |
| Beta | 1.37 |
| 1 Month Change | 1.66% |
| 3 Month Change | 7.55% |
| 1 Year Change | -5.08% |
| 3 Year Change | 1.22% |
| 5 Year Change | 115.32% |
| Change since IPO | 128.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| I1DX34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 6.7% | -0.8% | -0.6% |
| 1Y | -5.1% | 10.5% | -7.3% |
Return vs Industry: I1DX34 underperformed the BR Medical Equipment industry which returned 10.5% over the past year.
Return vs Market: I1DX34 exceeded the BR Market which returned -7.3% over the past year.
Price Volatility
| I1DX34 volatility | |
|---|---|
| I1DX34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in BR Market | 9.7% |
| 10% least volatile stocks in BR Market | 3.2% |
Stable Share Price: I1DX34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine I1DX34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 11,000 | Jay Mazelsky | www.idexx.com |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.
IDEXX Laboratories, Inc. Fundamentals Summary
| I1DX34 fundamental statistics | |
|---|---|
| Market cap | R$217.26b |
| Earnings (TTM) | R$5.12b |
| Revenue (TTM) | R$22.45b |
42.5x
P/E Ratio9.7x
P/S RatioIs I1DX34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| I1DX34 income statement (TTM) | |
|---|---|
| Revenue | US$3.90b |
| Cost of Revenue | US$1.52b |
| Gross Profit | US$2.38b |
| Other Expenses | US$1.49b |
| Earnings | US$887.87m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.84 |
| Gross Margin | 61.04% |
| Net Profit Margin | 22.78% |
| Debt/Equity Ratio | 54.4% |
How did I1DX34 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 16:39 |
| End of Day Share Price | 2025/02/04 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IDEXX Laboratories, Inc. is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Ishan Majumdar | Baptista Research |
| Balaji Prasad | Barclays |